These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2132778)

  • 1. Drug use trends in a nuclear power facility: data from a random screening program.
    Osborn CE; Sokolov JJ
    NIDA Res Monogr; 1990; 100():63-77. PubMed ID: 2132778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use trends in a nuclear power company: cumulative data from an ongoing testing program.
    Osborn CE; Sokolov JJ
    NIDA Res Monogr; 1989; 91():69-80. PubMed ID: 2509935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of employer anti-drug programs.
    Hayghe H
    NIDA Res Monogr; 1990; 100():177-207. PubMed ID: 2132771
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug screening in the workplace: use, abuse and implications.
    Grabowski J; Silverman PB
    NIDA Res Monogr; 1989; 95():225-31. PubMed ID: 2640968
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug screening in an Austrian prison].
    Lapornik R; Lehofer M; Rous F; Klampfer H; Hofmann P; Zapotoczky HG
    Nervenarzt; 1994 Sep; 65(9):633-4. PubMed ID: 7991011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The user in the next cubicle.
    Finley M
    Minn Med; 2007 Sep; 90(9):16-7. PubMed ID: 17966256
    [No Abstract]   [Full Text] [Related]  

  • 7. Research on drugs and the workplace: introduction and summary.
    Gust SW; Crouch DJ; Walsh JM
    NIDA Res Monogr; 1990; 100():3-8. PubMed ID: 2132776
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More employers are utilizing drug-screening programs.
    Bitter J
    Occup Health Saf; 1990 Apr; 59(4):27-32. PubMed ID: 2336234
    [No Abstract]   [Full Text] [Related]  

  • 11. Mandatory post-accident drug and alcohol testing for the Federal Railroad Administration: a comparison of results for two consecutive years.
    Moody DE; Crouch DJ; Andrenyak DM; Smith RP; Wilkins DG; Hoffman AM; Rollins DE
    NIDA Res Monogr; 1990; 100():79-96. PubMed ID: 2132779
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug screening in "normal" controls.
    Swerdlow NR; Geyer MA; Perry W; Cadenhead K; Braff DL
    Biol Psychiatry; 1995 Jul; 38(2):123-4. PubMed ID: 7578645
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-testing service agencies.
    Smith RB
    Occup Health Saf; 1990 Apr; 59(4):33. PubMed ID: 2336235
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation of drug use and urine screening patterns.
    Crosby RD; Carlson GA; Specker SM
    J Addict Dis; 2003; 22(3):89-98. PubMed ID: 14621347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minnesota workplace drug testing. Analysis of policy and procedures.
    Reynolds JL; McGovern PM; Kochevar L; Olson DK; Hibbs BF
    AAOHN J; 1991 Nov; 39(11):523-33. PubMed ID: 1930387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal aspects of urine screening.
    Schroeder EP
    NIDA Res Monogr; 1989; 95():218-24. PubMed ID: 2640967
    [No Abstract]   [Full Text] [Related]  

  • 20. Health indicators of substance abuse problems in Baltimore.
    DeWeese J; Liu H
    Md Med J; 1993 Aug; 42(8):751-9. PubMed ID: 8412536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.